Bioceptive Nominated for $250,000 Award to Test New Women’s Health Device

The New Orleans-based women’s health company Bioceptive has been nominated for a grant totaling $250,000 from Saving Lives at Birth: A Grand Challenge for Development. The company plans to test one of their novel medical devices in clinics in the developing world.

bioceptiveMore than 750 applications were received but only 17 were chosen as the final nominees.

Saving Lives at Birth is a partnership between the U.S. Agency for International Development (USAID), the Bill & Melinda Gates Foundation and many others including organizations and governments outside of the United States.

The Challenge is identifying innovation prevention and treatment solutions to save the lives of mothers and newborns around the world.

“Numerous studies have shown that improved access to family planning and control over birth spacing can save the lives of hundreds of thousands of women and infants,” said Shuchi ‘SK’ Khurana, COO at Bioceptive. “This award and the relationships developed with international partners of the Saving Lives at Birth program over the last three years will be instrumental in helping us bring our product to women in need in low-resource settings around the world.”